Results 121 to 130 of about 20,877 (183)

ABCG2 Genetic Variability in Drug Exposure and Toxicity: Implications for Clinical Practice. [PDF]

Toxics
Božina T, Šimičević L, Ganoci L, Lovrić M, Klarica Domjanović I, Trkulja V, Božina N.   +6 more
europepmc   +1 more source

Trimetazidine and allopurinol for the prevention of Contrast-associated acute kidney injury in elective percutaneous coronary intervention: a randomized controlled trial. [PDF]

Eur J Clin Pharmacol
Ali NO, Bazan NS, Mowafy HH, Abdelrahim MEA, Harb HS.   +4 more
europepmc   +1 more source

Severe Tophaceous Gout After Decades of Progressive Disease: A Case Report. [PDF]

Cureus
Weiderman G, Jianu NC, Karastury S, Mann P, Lorenz N, Jianu A, Walsh D.   +6 more
europepmc   +1 more source

Allopurinol Reprograms Uric Acid Self-Assembly by Disrupting Cytotoxic Fibrils and Redirecting Crystal Growth. [PDF]

JACS Au
Laor Bar-Yosef D, Oluwatoba DS, Adsi H, Safoah HA, Tiwari OS, Sogolovsky-Bard I, Zaguri D, Levy D, Gazit E, Do TD.   +9 more
europepmc   +1 more source

Dose-Sparing Efficacy of d-Limonene with Low-Dose Allopurinol in a Dual Model of Hyperuricemia and Gouty Arthritis in Rats. [PDF]

Nutrients
Venkatesan K, Muralidharan P, Sivadasan D, Pichaivel M, Asiri YI, Asseri KA, Sirag N, Elfadil H, Elodemi M, Prabahar K, Paulsamy P, Chidambaram K.   +11 more
europepmc   +1 more source

Gout-Related Medication Use After Initiating Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Gout and Type 2 Diabetes: Population-Based Target Trial Emulation Studies. [PDF]

Diabetes Care
McCormick N, Burrack N, Yokose C, Lu N, Wexler DJ, Rai SK, Challener GJ, Aviña-Zubieta JA, McCoy RG, Abuhasira R, Choi HK.   +10 more
europepmc   +1 more source

Assessing willingness to pay for HLA-B*58:01 genetic testing before allopurinol initiation and its potential impact on future health policy, Thailand. [PDF]

Sci Rep
Towiwat P, Bamrungsawad N, Buttham B, Nakham A, Upakdee N.   +4 more
europepmc   +1 more source

Combination of sodium-glucose cotransporter type 2 inhibitors and urate-lowering therapy in people with gout from a specialist clinic: a retrospective, single-center observational study. [PDF]

Front Med (Lausanne)
Doménech-Serrano J, García-Loiseau I, Rodríguez-Alvear C, Riesgo-Sanchis P, Moreno-Pérez Ó, Andrés M.   +5 more
europepmc   +1 more source

Gout prevalence and management strategies among patients with moderate to advanced chronic kidney disease. [PDF]

J Bras Nefrol
Sylvertooth D, Bieber B, Pecoits-Filho R, Marder B, LaMoreaux B, Karaboyas A.   +5 more
europepmc   +1 more source